Search Results 391-400 of 17818 for Coagulate

1. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

   Presence of other clinically significant risk of bleeding events, including coagulation or platelet disorders, at the Screening Visit as determined by the ...

2. A Study to Evaluate Estetrol to Treat Moderate-to-Severe Vasomotor Symptoms in Postmenopausal Women - Mayo Clinic

   History of known acquired of congenital coagulopathy or abnormal coagulation factors, including known thrombophilia's; 8. Diabetes mellitus with poor ...

3. Creative Commons creativecommons licenses.

4. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus with Radiofrequency Ablation - Mayo Clinic

   ... coagulation, or laser treatment) with the exception of a single treatment ... coagulation for focal residual disease following otherwise successful RFA therapy.

5. Molecular Analysis of Esophageal Samples Using a Minimally Invasive Collection Device - Mayo Clinic

   Patients with prior history of ablation (photodynamic therapy, radiofrequency ablation, cryotherapy, argon plasma coagulation). Patients with history of ...

6. A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy - Mayo Clinic

   Subject must have adequate coagulation, renal, and hepatic function, per laboratory reference range at Screening. Exclusion Criteria: Exhibits evidence of ...

7. Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) (VAYHIT1) - Mayo Clinic

   - Prior use of B-cell depleting therapy (e.g., rituximab). - Absolute neutrophil count below 1.0 G/L at randomization - Participants with concurrent coagulation ...

8. A Study to Investigate the Effectiveness of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis - Mayo Clinic

   ... coagulation, immunological, endocrine/metabolic, or other medical disorder that, in the opinion of the investigator, might confound study results, pose ...

9. Radiation Therapy with Durvalumab or Cetuximab to Treat Patients with Locoregionally Advanced Head and Neck Cancer who Cannot Take Cisplatin - Mayo Clinic

   Clinically apparent jaundice and/or known coagulation defects; Active or prior documented autoimmune or inflammatory disorders (including inflammatory bowel ...

10. A Study to Evaluate Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer - Mayo Clinic

    - Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects or severe liver dysfunction - Acquired immune deficiency syndrome (AIDS) ...